Publicacións nas que colabora con Daniel Ayude Vazquez (11)

2014

  1. Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients

    PLoS ONE, Vol. 9, Núm. 9

2013

  1. Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer

    BMC Cancer, Vol. 13

2009

  1. Soluble CD26 levels and its association to epidemiologic parameters in a sample population

    Disease Markers, Vol. 27, Núm. 6, pp. 311-316

2004

  1. Clinical significance of preoperative serum sialic acid levels in colorectal cancer: Utility in the detection of patients at high risk of tumor recurrence

    International Journal of Biological Markers, Vol. 19, Núm. 1, pp. 38-45

  2. Concanavalin a chromatography coupled to two-dimensional gel electrophoresis improves protein expression studies of the serum proteome

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 803, Núm. 2, pp. 337-343

2003

  1. Clinical interest of the combined use of serum CD26 and alpha-L-fucosidase in the early diagnosis of colorectal cancer

    Disease Markers, Vol. 19, Núm. 6, pp. 267-272

  2. Combined use of established and novel tumour markers in the diagnosis of head and neck squamous cell carcinoma

    Oncology Reports, Vol. 10, Núm. 5, pp. 1345-1350

  3. Preoperative serum alpha-L-fucosidase activity as a prognostic marker in colorectal cancer

    Oncology, Vol. 64, Núm. 1, pp. 36-45

2000

  1. Preoperative serum CD26 levels: Diagnostic efficiency and predictive value for colorectal cancer

    British Journal of Cancer, Vol. 83, Núm. 9, pp. 1139-1146

  2. Value of the serum alpha-L-fucosidase activity in the diagnosis of colorectal cancer

    Oncology, Vol. 59, Núm. 4, pp. 310-316

  3. α-L-fucosidase enzyme in the prediction of colorectal cancer patients at high risk of tumor recurrence

    Cancer Detection and Prevention, Vol. 24, Núm. 2, pp. 143-149